Refractive outcome after bilateral implantation of an apodized diffractive intraocular lens

Evaluation of the results of the first 30 patients, bilaterally implanted with the bifocal Acrysof Restor Apodized Diffractive intraocular lens (IOL) (SA60D3). The optics of this lens are designed to restore near and distance vision.

Department of Ophthalmology, Aalsters Stedelijk Ziekenhuis, Aalst, Belgium.

Sixty eyes of 30 patients had implantation of the Alcon Acrysof Restor SA60D3 IOL in this prospective nonrandomized clinical study. Fourty-eight eyes were evaluated at 6 months and 60 eyes at 3 months. Patient selection included no other eye disease besides cataract and corneal astigmatism of one diopter or less. Uncorrected distance visual acuity (UCVA-D), uncorrected near visual acuity (UCVAN), best corrected distance visual acuity (BCVA-D) and distance corrected near visual acuity (DCVA-N) were recorded. Glare phenomena, halos and night vision difficulties were evaluated as well as patient satisfaction.

Postoperative UCVA-D was better than 20/ 40 at 3 months and better than 20/30 at 6 months in all eyes. UCVA-N was equal or better than Jaeger (J) 3 at 3 months in 91% and all eyes achieved J3 or better at 6 months. BCVA-D was 20/30 or better in all eyes at 3 months and 20/25 or better at 6 months. DCVA-N was J2 or better in all eyes at 3 and 6 months. Patient satisfaction was excellent (76%), good (10%) or acceptable (14%). No patient was dissatisfied with the result. Twenty percent of patients mentioned glare or halos when specifically asked.

3- and 6-month data indicate that the Acrysof Restor Apodized diffractive IOL (SA60D3) provides excellent near visual acuity without compromising distance visual acuity. The incidence of visual disturbances is low and patient satisfaction high.